New patent for Alnylam Pharms drug OXLUMO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for OXLUMO
Annual Drug Patent Expirations for OXLUMO

Oxlumo is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are eleven patents protecting this drug.

This drug has one hundred and eight patent family members in thirty-six countries.

The generic ingredient in OXLUMO is lumasiran sodium. Additional details are available on the lumasiran sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top